ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,134Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 345

$923K Total Retail Price of All Prescriptions

Rank: 2 out of 345

1,309 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 17,268 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
METOPROLOL TARTRATE 2,078 1,682 10 1 4
SIMVASTATIN 1,233 1,031 2 7
FUROSEMIDE 1,232 970 3 6
ATORVASTATIN CALCIUM 1,031 808 4 9
METOPROLOL SUCCINATE 977 795 5 3
HYDROCHLOROTHIAZIDE 838 704 6 17
WARFARIN SODIUM 812 706 7 8
AMLODIPINE BESYLATE 734 573 8 5
PRAVASTATIN SODIUM 731 558 9 14
LISINOPRIL 721 518 10 1
CLOPIDOGREL 622 431 11 11
ENALAPRIL MALEATE 590 472 12 32
PLAVIX 394 282 13 16
CARVEDILOL 377 276 14 2
HYDRALAZINE HCL 372 288 15 34
ATENOLOL 341 282 16 13
LOSARTAN POTASSIUM 336 293 17 12
OMEPRAZOLE 333 232 18 26
LOSARTAN-HYDROCHLOROTHIAZIDE 325 286 19 35
QUINAPRIL HCL 270 228 20 73
LEVOTHYROXINE SODIUM 267 245 21 27
RAMIPRIL 260 218 22 31
LIPITOR 258 195 23 43
ZETIA 245 157 24 28
CRESTOR 241 196 25 15
SPIRONOLACTONE 234 185 26 19
FENOFIBRATE 223 167 27 47
KLOR-CON M20 216 157 28 30
POTASSIUM CHLORIDE 208 154 29 23
BENAZEPRIL HCL 166 127 30 62
NIASPAN 165 103 31 44
METFORMIN HCL 158 122 32 38
NITROSTAT 154 91 33 24
SOTALOL 148 130 34 33
NEXIUM 143 64 35 55
DIOVAN HCT 143 137 35 51
ISOSORBIDE MONONITRATE ER 142 94 37 10
DIGOXIN 138 77 38 18
PANTOPRAZOLE SODIUM 118 82 39 54
GLIMEPIRIDE 116 70 40 64
LISINOPRIL-HYDROCHLOROTHIAZIDE 115 71 41 42
VYTORIN 112 91 42 79
AMIODARONE HCL 111 104 43 21
COUMADIN 110 89 44 99
MELOXICAM 102 89 45 101
ZOLPIDEM TARTRATE 100 64 46 56
RANITIDINE HCL 96 50 47 49
AMLODIPINE BESYLATE-BENAZEPRIL 94 86 48 67
DIOVAN 92 75 49 25
ALLOPURINOL 91 67 50 59
BYSTOLIC 79 58 51 22
DOXAZOSIN MESYLATE 71 71 52 83
TORSEMIDE 66 48 53 69
GEMFIBROZIL 66 58 53 82
BENICAR HCT 65 52 55 104
CITALOPRAM HBR 64 45 56 95
EFFIENT 60 33 57 58
PACERONE 57 33 58 92
TRICOR 56 56 59 90
SYNTHROID 55 53 60 112
NIFEDIPINE ER 55 53 60 50
PAROXETINE HCL 55 55 60 157
PRADAXA 54 46 63 20
GLIPIZIDE 52 37 64 103
DILTIAZEM 24HR ER 52 45 64 29
LABETALOL HCL 52 44 64 74
TAMSULOSIN HCL 52 48 64 72
LOVASTATIN 50 34 68 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.